Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis

ObjectivesAlthough the use of neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma is increasing, the optimal preoperative treatment regimen remains poorly defined.MethodsAll patients with resectable pancreatic ductal adenocarcinoma who received preoperative chemotherapy alone (12%) o